908 Devices - MASS Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $8.00
  • Forecasted Upside: 294.09%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$2.03
▼ -0.12 (-5.58%)

This chart shows the closing price for MASS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New 908 Devices Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MASS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MASS

Analyst Price Target is $8.00
▲ +294.09% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for 908 Devices in the last 3 months. The average price target is $8.00, with a high forecast of $14.00 and a low forecast of $4.00. The average price target represents a 294.09% upside from the last price of $2.03.

This chart shows the closing price for MASS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 4 contributing investment analysts is to moderate buy stock in 908 Devices. This rating has held steady since October 2024, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/27/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/25/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/24/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/23/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/21/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/19/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/18/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/18/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/13/2024Leerink PartnrsDowngradeStrong-Buy ➝ Hold
11/13/2024Stifel NicolausLower TargetBuy ➝ Buy$17.00 ➝ $6.00
11/13/2024Leerink PartnersReiterated RatingOutperform ➝ Market Perform$12.00 ➝ $4.00
10/17/2024Leerink PartnersLower TargetOutperform ➝ Outperform$15.00 ➝ $12.00
5/13/2024StephensReiterated RatingOverweight ➝ Overweight$14.00
9/25/2023StephensReiterated RatingOverweight ➝ Overweight$14.00
2/6/2023StephensInitiated CoverageOverweight$14.00
1/6/2023Leerink PartnersLower TargetOutperform$25.00 ➝ $20.00
11/15/2022Leerink PartnersLower TargetOutperform$30.00 ➝ $25.00
3/8/2022Leerink PartnersLower TargetOutperform$40.00 ➝ $30.00
8/8/2021Leerink PartnersReiterated RatingBuy
5/14/2021Leerink PartnersLower TargetOutperform$70.00 ➝ $65.00
1/12/2021William BlairInitiated CoverageOutperform
1/12/2021Leerink PartnersInitiated CoverageOutperform$70.00
1/12/2021Stifel NicolausInitiated CoverageBuy$65.00
1/12/2021CowenInitiated CoverageOutperform$74.00
(Data available from 12/18/2019 forward)

News Sentiment Rating

1.68 (Strong Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 10 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
5/22/2024
  • 3 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
6/21/2024
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/21/2024
  • 3 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
8/20/2024
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/19/2024
  • 2 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/19/2024
  • 3 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
11/18/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/18/2024

Current Sentiment

  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.
908 Devices logo
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Read More

Today's Range

Now: $2.03
Low: $2.01
High: $2.18

50 Day Range

MA: $2.94
Low: $2.03
High: $3.91

52 Week Range

Now: $2.03
Low: $2.00
High: $12.51

Volume

222,360 shs

Average Volume

211,693 shs

Market Capitalization

$70.69 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92

Frequently Asked Questions

What sell-side analysts currently cover shares of 908 Devices?

The following Wall Street sell-side analysts have issued stock ratings on 908 Devices in the last year: Leerink Partners, Leerink Partnrs, Stephens, and Stifel Nicolaus.
View the latest analyst ratings for MASS.

What is the current price target for 908 Devices?

0 Wall Street analysts have set twelve-month price targets for 908 Devices in the last year. Their average twelve-month price target is $8.00, suggesting a possible upside of 294.1%. Stephens has the highest price target set, predicting MASS will reach $14.00 in the next twelve months. Leerink Partners has the lowest price target set, forecasting a price of $4.00 for 908 Devices in the next year.
View the latest price targets for MASS.

What is the current consensus analyst rating for 908 Devices?

908 Devices currently has 2 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for MASS.

What other companies compete with 908 Devices?

How do I contact 908 Devices' investor relations team?

The company's listed phone number is 857-254-1500 and its investor relations email address is [email protected]. The official website for 908 Devices is www.908devices.com. Learn More about contacing 908 Devices investor relations.